Contact us at firstname.lastname@example.org to share your experiences of buying medicines online, or receiving medicines from your pharmacist which have seemed out of the ordinary.
The European Alliance for Access to Safe Medicines (EAASM) is an independent, pan-European initiative dedicated to protecting patient safety by ensuring access to safe and legitimate medicines. The Alliance was formed by a cross-section of European stake-holders from a variety of backgrounds. Its key activities include campaigning for the safer use of unlicensed or off-label medicines and also the exclusion of counterfeit and substandard medicines from the supply chain, raising public awareness around such issues, and promoting effective legislation and enforcement in relation to falsified medicines. For a leaflet summarising the EAASM's activities and achievements click here
On this website you will find a wealth of information about counterfeit and substandard medicines. Our top tips section will help you to reassure yourself that the prescription medicine you are buying is genuine. Our news section will provide you with the latest news on counterfeit medicines in Europe and around the world as well as updates about the EAASM activities. The EAASM constantly updates and adds useful resources to the website so you can get as much information as possible about obtaining safe medicines.
24 Aug 2016
A public awareness raising campaign has been launched which is aimed at young adults warning of the dangers of buying dodgy diet pills online.
29 Mar 2016
Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or the ‘Group’) the global pharmaceutical and services company has become a full member of the European Alliance for Access to Safe Medicines (EAASM) and Alliance for Safe Online Pharmacy in the EU (ASOP EU), both aiming to protect patients from the dangers of falsified or counterfeit medicines.
22 Dec 2015
ASOP EU participated in the FAKECARE conference hosted by the Faculty of Law, University of Trento 17-18th December 2015. The conference brought together the team of “Project FAKECARE” comprising university researchers, supported by institutional actors and other relevant stakeholders, which had adopted a multidisciplinary and integrated approach (law, criminology, statistical and information science).